Tumor Biology

, Volume 35, Issue 12, pp 12713–12719 | Cite as

miR-204-5p expression in colorectal cancer: an autophagy-associated gene

  • Ahmet Taner Sümbül
  • Bülent Göğebakan
  • Sercan Ergün
  • Erhan Yengil
  • Celal Yücel Batmacı
  • Önder Tonyalı
  • Mehmet Yaldız
Research Article


MicroRNAs (miRNAs) are important factors during tumorigenesis by affecting posttranscriptional gene expression. miRNA 204 (miR-204) is a miRNA frequently investigated in different types of cancers. According to literature, autophagy has dual roles in cancer, acting as both a tumor suppressor and cell survival agent. Also, the current data suggests that autophagy is activated in human colorectal cancer cells and enhances the aggressiveness of human colorectal cancer cells. So, our aim is to investigate potential effect of miR-204-5p on colorectal cancer by associating its expression with autophagy-related targets of miR-204-5p. This is the first miRNA study conducted on patients with colorectal cancer and healthy subjects and also to search the relation of miR-204-5p with clinicopathological factors and survival. Sixty-six patients with colorectal cancer and healthy subjects without any known chronic disease were enrolled into our study. Total miRNA was isolated from paraffin-embedded tissues of all patients’ cancerous and normal tissues, and healthy subjects. cDNAs were obtained from this miRNAs by reverse transcriptase method, and miR-204-5p relative expression levels were detected by qRT-PCR method. Patients were divided into two groups according to median relative expression levels of miR-204-5p, as low- and high-expression group. Relation of miR-204-5p with clinicopathological factors and overall survival was also investigated. Medians of miR-204-5p relative expression levels in cancerous and normal tissues of patients were found as 0.00235 and 0.00376, respectively. The difference between two groups was not statistically significant (p = 0.11). Nonetheless, median of miR-204-5p relative expression levels in healthy subjects were found as 0.00135, and the difference between patient with cancer and healthy subjects and between normal tissues of patients and healthy subjects were statistically significant (p = 0.021 and p = 0.0005, respectively). There were 32 patients (48.5 %) showing high expression and 34 patients (51.5 %) showing low expression according to miR-204-5p relative expression levels. There were no statistically significant relation between clinicopathologic features and miR-204-5p relative expression levels. We also investigated the relation between miR-204-5p relative expression levels and overall survival, and no statistically significant relation was found between them (p = 0.462). The absence of any significant difference between tumor and non-tumor samples, low sample size, and performance at just one center are the limitations of our study. In opposition to literature, miR-204-5p is overexpressed in colorectal cancer patients as compared with healthy subjects and this situation is not associated with clinicopathological factors and overall survival. This may be explained by the fact that miR-204-5p increases in colorectal cancer cases in order to inhibit increased activity of LC3B-II in autophagy and Bcl2 against apoptosis posttranscriptionally and to take role as tumor suppressor.


Colorectal cancer miR-204-5p LC3B-II Bcl2 Clinicopathological factors 


  1. 1.
    Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062–75.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97–110.PubMedCrossRefGoogle Scholar
  3. 3.
    Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun. 2004;313(2):453–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Shibutani ST, Tamotsu Y. A current perspective of autophagosome biogenesis. Cell Res. 2014;24(1):58–68.PubMedCrossRefGoogle Scholar
  5. 5.
    Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 2007;67(20):9677–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Waldman SA, Terzic A. Translating MicroRNA discovery into clinical biomarkers in cancer. JAMA. 2007;297(17):1923–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.PubMedCrossRefGoogle Scholar
  9. 9.
    Esquela-Kerscher A, Slack FJ. Oncomirs–microRNAs with a role in cancer. Nat Rev Cancer. 2006; 259–269.Google Scholar
  10. 10.
    Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma, JAMA. 2008; 425–436.Google Scholar
  11. 11.
    Saadi JI, Plyler JR, Hima B, Suresh P, Sanjay B, Jennifer R, et al. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and ınvasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One. 2012;7(12):e52397.CrossRefGoogle Scholar
  12. 12.
    Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Role of miR-204-5p in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52:2999–3007.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Cui RR, Li SJ, Liu LJ, Yi L, Liang QH, et al. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res. 2012;96:320–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Gong M, Ma J, Li M, Zhou M, Hock JM, et al. MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro Oncol. 2012;14:1007–17.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer. 2012;130:1036–45.PubMedCrossRefGoogle Scholar
  16. 16.
    Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113(1):25–36.PubMedCrossRefGoogle Scholar
  17. 17.
    Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432(7014):226–30.PubMedCrossRefGoogle Scholar
  18. 18.
    Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604–8.PubMedCrossRefGoogle Scholar
  19. 19.
    He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435(7043):828–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006;124(6):1169–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Johnson SM, Grosshans H, Shingara J. RAS is regulated by the let-7 microRNA family. Cell. 2005;120(5):635–47.PubMedCrossRefGoogle Scholar
  22. 22.
    Chao-Jie W, Zong-Guang Z, Ling W, Lie Y, Bin Z, Jun G, et al. Clinicopathological significance of microRNA-31, −143 and −145 expression in colorectal cancer. Dis Markers. 2009;26:27–34.CrossRefGoogle Scholar
  23. 23.
    Zhou T, Zhang G, Liu Z, Xia S, Tian H. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorectal Dis. 2013;28:19–24.PubMedCrossRefGoogle Scholar
  24. 24.
    Liu H, Du L, Wen Z, Yang Y, Li J, Wang L, et al. Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. Int J Colorectal Dis. doi:10.1007/s00384-013-1674-0.
  25. 25.
    Zhou T, Zhang G-J, Zhou H, Xiao H-X, Li Y. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Eur J Gastroenterol Hepatol 2014, 26 No 2.Google Scholar
  26. 26.
    Zhang G, Xia S, Tian H, Liu Z, Zhou T. Clinical significance of miR-22 expression in patients with colorectal cancer. Med Oncol. 2012;29:3108–12.PubMedCrossRefGoogle Scholar
  27. 27.
    Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, et al. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg. 2013 (epub ahead print).Google Scholar
  28. 28.
    Yu H, Gao G, Jiang L, Guo L, Lin M, Jiao X, et al. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol. 2013;15;6(12):2904–11.Google Scholar
  29. 29.
    Chen Z, Sangwan V, Banerjee S, Mackenzie T, Dudeja V, Li X, et al. miR-204-5p mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death. Mol Cancer. 2013;12(1):105.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H, et al. Loss of miR-204-5p expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 2013;73(2):990–9.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L, et al. miR-204-5p targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis. 2012;3:e423.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, et al. Network modeling identifies molecular functions targeted by miR-204-5p to suppress head and neck tumor metastasis. PLoS Comput Biol. 2010;6(4):e1000730.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Zheng H, Zhang X, Wang X, Sun B. Autophagy enhances the aggressiveness of human colorectal cancer cells and their ability to adapt to apoptotic stimulus. Cancer Biol Med. 2012;9:105–10.PubMedCentralPubMedGoogle Scholar
  34. 34.
    Drullion C, Trégoat C, Lagarde V, Tan S, Gioia R, Priault M, et al. Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis. 2012;3:e373.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Xu D, Wang C, Shen X, Yu Y, Rui Y2, Zhang D, et al. Apoptotic block in colon cancer cells may be rectified by lentivirus mediated overexpression of caspase-9. Acta Gastroenterol Belg. 2013;76(4):372–80.PubMedGoogle Scholar
  36. 36.
    Mikhaylova O, Stratton Y, Hal D, Kellner E, Ehmer B, Drew AF, et al. VHL-regulated miR-204-5p suppresses tumor growth through ınhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21(4):532–46.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Wang X, Wang J, Ma H, Zhang J, Zhou X. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol. 2012;29:919–27.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Ahmet Taner Sümbül
    • 1
  • Bülent Göğebakan
    • 2
  • Sercan Ergün
    • 3
  • Erhan Yengil
    • 4
  • Celal Yücel Batmacı
    • 5
  • Önder Tonyalı
    • 1
  • Mehmet Yaldız
    • 6
  1. 1.Department of Medical Oncology, Medical FacultyMustafa Kemal UniversityHatayTurkey
  2. 2.Department of Medical Biology and Genetics, Medical FacultyMustafa Kemal UniversityHatayTurkey
  3. 3.Department of Medical Biology, Medical FacultyGaziantep UniversityHatayTurkey
  4. 4.Department of Family Medicine, Medical FacultyMustafa Kemal UniversityHatayTurkey
  5. 5.Department of Internal Medicine, Medical FacultyMustafa Kemal UniversityHatayTurkey
  6. 6.Department of Pathology, Medical FacultyMustafa Kemal UniversityHatayTurkey

Personalised recommendations